205 related articles for article (PubMed ID: 23901271)
1. Formulation design, preparation, and in vitro and in vivo characterizations of β-Elemene-loaded nanostructured lipid carriers.
Shi F; Yang G; Ren J; Guo T; Du Y; Feng N
Int J Nanomedicine; 2013; 8():2533-41. PubMed ID: 23901271
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
3. Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect.
Rahman HS; Rasedee A; How CW; Abdul AB; Zeenathul NA; Othman HH; Saeed MI; Yeap SK
Int J Nanomedicine; 2013; 8():2769-81. PubMed ID: 23946649
[TBL] [Abstract][Full Text] [Related]
4. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
Abd-Elhakeem E; El-Nabarawi M; Shamma R
Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
[TBL] [Abstract][Full Text] [Related]
5. Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers.
Chen Y; Zhou L; Yuan L; Zhang ZH; Liu X; Wu Q
Int J Nanomedicine; 2012; 7():3023-32. PubMed ID: 22787398
[TBL] [Abstract][Full Text] [Related]
6. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
Song A; Zhang X; Li Y; Mao X; Han F
Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
[TBL] [Abstract][Full Text] [Related]
7. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments.
Soni K; Rizwanullah M; Kohli K
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers.
Cao C; Wang Q; Liu Y
Drug Des Devel Ther; 2019; 13():1087-1098. PubMed ID: 31118562
[No Abstract] [Full Text] [Related]
9. Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies.
Ahmad A; Abuzinadah MF; Alkreathy HM; Banaganapalli B; Mujeeb M
PLoS One; 2018; 13(3):e0193451. PubMed ID: 29558494
[TBL] [Abstract][Full Text] [Related]
10. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
11. Nose to Brain Delivery of Astaxanthin-Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer's Disease: Preparation, in vitro and in vivo Evaluation.
Shehata MK; Ismail AA; Kamel MA
Int J Nanomedicine; 2023; 18():1631-1658. PubMed ID: 37020692
[TBL] [Abstract][Full Text] [Related]
12. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
13. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
Wang W; Chen L; Huang X; Shao A
AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
[TBL] [Abstract][Full Text] [Related]
15. Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus.
Yu Q; Hu X; Ma Y; Xie Y; Lu Y; Qi J; Xiang L; Li F; Wu W
Drug Deliv; 2016 May; 23(4):1469-75. PubMed ID: 27187522
[TBL] [Abstract][Full Text] [Related]
16. Preparation, optimization and characteristic of huperzine a loaded nanostructured lipid carriers.
Yang CR; Zhao XL; Hu HY; Li KX; Sun X; Li L; Chen DW
Chem Pharm Bull (Tokyo); 2010 May; 58(5):656-61. PubMed ID: 20460792
[TBL] [Abstract][Full Text] [Related]
17. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
18. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy.
Zhang G; Liu F; Jia E; Jia L; Zhang Y
Drug Deliv; 2016 May; 23(4):1393-7. PubMed ID: 26165422
[TBL] [Abstract][Full Text] [Related]
19. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.
Ranpise NS; Korabu SS; Ghodake VN
Colloids Surf B Biointerfaces; 2014 Apr; 116():81-7. PubMed ID: 24445002
[TBL] [Abstract][Full Text] [Related]
20. Ezetimibe-Loaded Nanostructured Lipid Carrier Based Formulation Ameliorates Hyperlipidaemia in an Experimental Model of High Fat Diet.
Agrawal YO; Mahajan UB; Agnihotri VV; Nilange MS; Mahajan HS; Sharma C; Ojha S; Patil CR; Goyal SN
Molecules; 2021 Mar; 26(5):. PubMed ID: 33803259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
